Samuel George A. III bought LCTX
March 5, 2026 · Form 4 insider transaction
Samuel George A. III bought 900,000 shares of Lineage Cell Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
900,000
Price
$0.00
Total value
N/A
InsiderSamuel George A. III
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 5, 2026
Filing dateMarch 6, 2026
Shares owned after900,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One quarter of the options shall vest on March 5, 2027, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.